Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Part of paid clinical trials in Brick, New Jersey.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT02688517
- Status
- Recruiting
Conditions
- Malignant Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cytology Specimen Collection Procedure — OTHERUndergo collection of blood samples
- Laboratory Biomarker Analysis — OTHERCorrelative studies
Study Details
This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.
Key Dates
- Start date
- Feb 28, 2013
- Status verified
- Apr 2026
- Primary completion
- May 31, 2030
- Completion
- May 31, 2030
Study Design
- Enrollment
- 1,100 participants (estimated)
Arms
- Arm: Ancillary-Correlative (genomic analysis)Previously collected tissue samples are analyzed for the presence of mutations via next generation sequencing. Patients may also undergo collection of blood samples for analysis of circulating cell-free DNA and circulating tumor cells.
Primary Outcome Measure
Frequencies of individual specific mutations and combinations of mutations of related pathway genes [ Time Frame: Up to 15 years ]
Central Contacts
- Clinical Trials Office732-235-2465
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ocean Medical Center | Brick | New Jersey | 08724 | - |
| Bayshore Community Hospital | Holmdel | New Jersey | 07733 | - |
| RWJBarnabas Health - Jersey City Medical Center, Jersey City | Jersey City | New Jersey | 07302 | Gregory Riedlinger |
| Southern Ocean County Medical Center | Manahawkin | New Jersey | 08050 | - |
| Morristown Medical Center | Morristown | New Jersey | 07960 | - |
| Jersey Shore Medical Center | Neptune City | New Jersey | 07753 | - |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | Clinical Trials Office 732-235-8675 Gregory Riedlinger (PRINCIPAL_INVESTIGATOR) |
| Riverview Medical Center | Red Bank | New Jersey | 07701 | - |
| Riverview Medical Center/Booker Cancer Center | Red Bank | New Jersey | 07701 | - |
| Overlook Hospital | Summit | New Jersey | 07902 | - |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | - |
Find similar trials in Brick, NJ
By research site
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Molecular Genetics Studies of Cancer Patients and Their RelativesRecruiting · City of Hope Medical Center · Phoenix, Arizona
- A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Birmingham, Alabama
- A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Los Angeles, California